Avatrombopag 20mg tablets
NHS hospitals in England used £26,944,768 of indicative cost of Avatrombopag 20mg tablets in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 37.5% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Avatrombopag 20mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Avatrombopag 20mg tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Western Sussex Hospitals Nhs Found Trust | £1,105,216 |
| Barts Health Nhs Trust | £989,504 |
| Imperial College Healthcare Nhs Trust | £983,552 |
| Manchester University Nhs Ft | £695,936 |
| Cambridge Univ Hosp Nhs Foundation Trust | £689,280 |
| Univ Hpl B/Ham Nhs Foundation Trust | £667,264 |
| Leeds Teaching Hpls Nhs Trust | £544,256 |
| University Hpls Of Leicester Nhs Trust | £542,336 |
| Luton & Dunstable Hospital Trust | £515,840 |
| Wwl Nhs Foundation Trust | £505,152 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.